Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tara C Mitchell

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
BMC Cancer|July 25, 2024
Valuable insights from the epacadostat plus pembrolizumab clinical trials in solid cancersTara C Mitchell
Nature Cancer|February 6, 2026
Immune checkpoint blockade in desmoplastic melanomaGeorge Mo, Tara C Mitchell
Immunotherapy|August 29, 2018
Immunotherapy in melanomaEmily Feld, Tara C Mitchell
Nature Reviews. Clinical Oncology|August 30, 2022
Personalizing the approach to neoadjuvant therapy: a promising path to improving outcomes of resectable melanomaGiorgos C Karakousis, Tara C Mitchell
Journal of Cutaneous Pathology|June 26, 2018
Pembrolizumab-induced sarcoidal infusion site reactionRobert J Smith, Tara C Mitchell, Emily Y Chu
Journal of Cutaneous Pathology|April 29, 2026
Multicentric Asynchronous Endocrine Mucin-Producing Sweat Gland Carcinoma and Mucinous Carcinoma of the SkinIkuko Hirai, Joseph F Sobanko, Tara C Mitchell, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2019
Association of Insurance Status With Presentation, Treatment, and Survival in Melanoma in the Era of Immune Checkpoint InhibitorsVarsha Jain, Sriram Venigalla, Vishruth K Reddy, et al.
The Oncologist|February 12, 2020
Association of Age with Efficacy of Immunotherapy in Metastatic MelanomaVarsha Jain, Wei-Ting Hwang, Sriram Venigalla, et al.
Annals of Surgical Oncology|June 18, 2023
Impact of Adjuvant Immunotherapy on Overall Survival in a Contemporary Cohort of Patients with Stage III MelanomaCimarron E Sharon, Gabriella N Tortorello, Kevin Ma, et al.
Seminars in Radiation Oncology|May 9, 2020
Combining Radiation with Immunotherapy: The University of Pennsylvania ExperienceLeo Y Luo, Mark H O'Hara, Tara C Mitchell, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
BMC Cancer|July 25, 2024
Valuable insights from the epacadostat plus pembrolizumab clinical trials in solid cancersTara C Mitchell
Nature Cancer|February 6, 2026
Immune checkpoint blockade in desmoplastic melanomaGeorge Mo, Tara C Mitchell
Immunotherapy|August 29, 2018
Immunotherapy in melanomaEmily Feld, Tara C Mitchell
Nature Reviews. Clinical Oncology|August 30, 2022
Personalizing the approach to neoadjuvant therapy: a promising path to improving outcomes of resectable melanomaGiorgos C Karakousis, Tara C Mitchell
Journal of Cutaneous Pathology|June 26, 2018
Pembrolizumab-induced sarcoidal infusion site reactionRobert J Smith, Tara C Mitchell, Emily Y Chu
Journal of Cutaneous Pathology|April 29, 2026
Multicentric Asynchronous Endocrine Mucin-Producing Sweat Gland Carcinoma and Mucinous Carcinoma of the SkinIkuko Hirai, Joseph F Sobanko, Tara C Mitchell, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2019
Association of Insurance Status With Presentation, Treatment, and Survival in Melanoma in the Era of Immune Checkpoint InhibitorsVarsha Jain, Sriram Venigalla, Vishruth K Reddy, et al.
The Oncologist|February 12, 2020
Association of Age with Efficacy of Immunotherapy in Metastatic MelanomaVarsha Jain, Wei-Ting Hwang, Sriram Venigalla, et al.
Annals of Surgical Oncology|June 18, 2023
Impact of Adjuvant Immunotherapy on Overall Survival in a Contemporary Cohort of Patients with Stage III MelanomaCimarron E Sharon, Gabriella N Tortorello, Kevin Ma, et al.
Seminars in Radiation Oncology|May 9, 2020
Combining Radiation with Immunotherapy: The University of Pennsylvania ExperienceLeo Y Luo, Mark H O'Hara, Tara C Mitchell, et al.
Pageof 7